logo
  

Dynatrace Guides Q1, FY21 Revenues Above Estimates - Quick Facts

While reporting financial results for the fourth quarter on Wednesday, software intelligence provider Dynatrace, Inc. (DT) initiated its adjusted earnings and revenue guidance for the full-year 2022 and provided outlook for the first quarter of fiscal 2022.

For fiscal 2022, the company now projects adjusted earnings in a range of $0.59 to $0.62 per share on total revenues between $885 million and $900 million.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $0.63 per share on revenues of $868.24 million for the year. Analysts' estimates typically exclude special items.

For the first quarter, the company projects adjusted earnings in the range of $0.14 to $0.15 per share on total revenues between $202 million and $204 million. The Street is looking for earnings of $0.14 per share on revenues of $197.04 million for the quarter.

"Looking forward to fiscal 2022, we will continue to invest in growth to take advantage of the large and growing market opportunity we have in front of us," stated John Van Siclen, Chief Executive Officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
RELATED NEWS
Follow RTT